Advanced supply chains could “be the vital catalyst for transforming life sciences to better meet increasing demand”, according to a new DHL report.
The report, ‘Future of Life Sciences and Healthcare Logistics”, says that it is urgent that the industry transforms to respond to changing patient needs and technology advancements.
“The Life Sciences and Healthcare market is dynamic and fast-paced and our customers are facing many challenges that will impact their supply chains such as advances in technology, new products, emerging markets, changing regulations and routes to market,” said Tim Slater, chief executive office, Life Sciences and Healthcare & NHS Supply Chain. “At DHL we aim to become the first port of call for our customers to support their business today and tomorrow, through offering bespoke solution design, great account management and first class change management expertise to support their journeys.”
